Go Pro

Equifax (EFX) Competitors

Equifax logo
$194.54 +1.92 (+1.00%)
Closing price 03:59 PM Eastern
Extended Trading
$194.80 +0.26 (+0.13%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EFX vs. CRAI, APTV, G, IQV, and IT

Should you buy Equifax stock or one of its competitors? Equifax's main competitors and comparable companies include Charles River Associates (CRAI), Aptiv (APTV), Genpact (G), IQVIA (IQV), and Gartner (IT). Companies are selected based on similarities in market, industry, and size.

How does Equifax compare to Charles River Associates?

Equifax (NYSE:EFX) and Charles River Associates (NASDAQ:CRAI) are both industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Equifax presently has a consensus price target of $216.89, suggesting a potential upside of 11.49%. Charles River Associates has a consensus price target of $245.00, suggesting a potential upside of 39.54%. Given Charles River Associates' higher probable upside, analysts clearly believe Charles River Associates is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.70
Charles River Associates
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.2%. Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.3%. Equifax pays out 39.4% of its earnings in the form of a dividend. Charles River Associates pays out 30.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has raised its dividend for 1 consecutive years and Charles River Associates has raised its dividend for 7 consecutive years. Charles River Associates is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

96.2% of Equifax shares are owned by institutional investors. Comparatively, 84.1% of Charles River Associates shares are owned by institutional investors. 1.7% of Equifax shares are owned by company insiders. Comparatively, 4.5% of Charles River Associates shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Equifax has a net margin of 10.73% compared to Charles River Associates' net margin of 6.20%. Charles River Associates' return on equity of 27.31% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax10.73% 21.61% 8.41%
Charles River Associates 6.20%27.31%8.36%

In the previous week, Equifax had 19 more articles in the media than Charles River Associates. MarketBeat recorded 22 mentions for Equifax and 3 mentions for Charles River Associates. Equifax's average media sentiment score of 1.37 beat Charles River Associates' score of 1.21 indicating that Equifax is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
17 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charles River Associates
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Equifax has higher revenue and earnings than Charles River Associates. Charles River Associates is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.76$660.30M$5.6934.19
Charles River Associates$751.58M1.47$54.78M$7.5123.38

Equifax has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Charles River Associates has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

Summary

Equifax beats Charles River Associates on 12 of the 19 factors compared between the two stocks.

How does Equifax compare to Aptiv?

Aptiv (NYSE:APTV) and Equifax (NYSE:EFX) are related large-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

Equifax has a net margin of 10.73% compared to Aptiv's net margin of 1.17%. Equifax's return on equity of 21.61% beat Aptiv's return on equity.

Company Net Margins Return on Equity Return on Assets
Aptiv1.17% 17.10% 7.03%
Equifax 10.73%21.61%8.41%

In the previous week, Equifax had 19 more articles in the media than Aptiv. MarketBeat recorded 22 mentions for Equifax and 3 mentions for Aptiv. Equifax's average media sentiment score of 1.37 beat Aptiv's score of 0.45 indicating that Equifax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aptiv
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Equifax
17 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aptiv presently has a consensus target price of $76.50, suggesting a potential upside of 61.48%. Equifax has a consensus target price of $216.89, suggesting a potential upside of 11.49%. Given Aptiv's stronger consensus rating and higher possible upside, analysts plainly believe Aptiv is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aptiv
2 Sell rating(s)
3 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.71
Equifax
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.70

Equifax has lower revenue, but higher earnings than Aptiv. Equifax is trading at a lower price-to-earnings ratio than Aptiv, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptiv$20.40B0.48$165M$1.0644.69
Equifax$6.07B3.76$660.30M$5.6934.19

94.2% of Aptiv shares are owned by institutional investors. Comparatively, 96.2% of Equifax shares are owned by institutional investors. 0.1% of Aptiv shares are owned by company insiders. Comparatively, 1.7% of Equifax shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aptiv has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, Equifax has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

Summary

Equifax beats Aptiv on 10 of the 16 factors compared between the two stocks.

How does Equifax compare to Genpact?

Genpact (NYSE:G) and Equifax (NYSE:EFX) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Genpact currently has a consensus price target of $39.33, suggesting a potential upside of 4.64%. Equifax has a consensus price target of $216.89, suggesting a potential upside of 11.49%. Given Equifax's stronger consensus rating and higher possible upside, analysts clearly believe Equifax is more favorable than Genpact.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genpact
0 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.22
Equifax
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.70

Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.0%. Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.2%. Genpact pays out 22.3% of its earnings in the form of a dividend. Equifax pays out 39.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has raised its dividend for 6 consecutive years and Equifax has raised its dividend for 1 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Genpact has a net margin of 11.04% compared to Equifax's net margin of 10.73%. Genpact's return on equity of 23.34% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Genpact11.04% 23.34% 10.68%
Equifax 10.73%21.61%8.41%

In the previous week, Equifax had 16 more articles in the media than Genpact. MarketBeat recorded 22 mentions for Equifax and 6 mentions for Genpact. Equifax's average media sentiment score of 1.37 beat Genpact's score of 0.44 indicating that Equifax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genpact
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Equifax
17 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Equifax has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genpact$5.08B1.24$552.49M$3.3711.15
Equifax$6.07B3.76$660.30M$5.6934.19

96.0% of Genpact shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 1.6% of Genpact shares are held by insiders. Comparatively, 1.7% of Equifax shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Genpact has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market. Comparatively, Equifax has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market.

Summary

Equifax beats Genpact on 13 of the 19 factors compared between the two stocks.

How does Equifax compare to IQVIA?

Equifax (NYSE:EFX) and IQVIA (NYSE:IQV) are related large-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

96.2% of Equifax shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 1.7% of Equifax shares are owned by company insiders. Comparatively, 1.7% of IQVIA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Equifax has a net margin of 10.73% compared to IQVIA's net margin of 8.10%. IQVIA's return on equity of 30.25% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Equifax10.73% 21.61% 8.41%
IQVIA 8.10%30.25%6.54%

In the previous week, IQVIA had 16 more articles in the media than Equifax. MarketBeat recorded 38 mentions for IQVIA and 22 mentions for Equifax. IQVIA's average media sentiment score of 1.51 beat Equifax's score of 1.37 indicating that IQVIA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Equifax
17 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IQVIA
33 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

IQVIA has higher revenue and earnings than Equifax. IQVIA is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Equifax$6.07B3.76$660.30M$5.6934.19
IQVIA$16.31B2.63$1.36B$8.0632.30

Equifax has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

Equifax presently has a consensus price target of $216.89, indicating a potential upside of 11.49%. IQVIA has a consensus price target of $241.88, indicating a potential downside of 7.08%. Given Equifax's higher probable upside, equities research analysts plainly believe Equifax is more favorable than IQVIA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Equifax
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.70
IQVIA
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.88

Summary

Equifax and IQVIA tied by winning 8 of the 16 factors compared between the two stocks.

How does Equifax compare to Gartner?

Gartner (NYSE:IT) and Equifax (NYSE:EFX) are both large-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

91.5% of Gartner shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 2.6% of Gartner shares are held by company insiders. Comparatively, 1.7% of Equifax shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Gartner has a net margin of 11.99% compared to Equifax's net margin of 10.73%. Gartner's return on equity of 525.46% beat Equifax's return on equity.

Company Net Margins Return on Equity Return on Assets
Gartner11.99% 525.46% 13.45%
Equifax 10.73%21.61%8.41%

Gartner has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, Equifax has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

In the previous week, Equifax had 4 more articles in the media than Gartner. MarketBeat recorded 22 mentions for Equifax and 18 mentions for Gartner. Equifax's average media sentiment score of 1.37 beat Gartner's score of 1.02 indicating that Equifax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Gartner
12 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Equifax
17 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Gartner presently has a consensus target price of $187.30, suggesting a potential downside of 7.60%. Equifax has a consensus target price of $216.89, suggesting a potential upside of 11.49%. Given Equifax's stronger consensus rating and higher probable upside, analysts clearly believe Equifax is more favorable than Gartner.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Gartner
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Equifax
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.70

Gartner has higher revenue and earnings than Equifax. Gartner is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gartner$6.50B1.97$729.23M$11.1518.18
Equifax$6.07B3.76$660.30M$5.6934.19

Summary

Equifax beats Gartner on 9 of the 17 factors compared between the two stocks.

Get Equifax News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EFX vs. The Competition

MetricEquifaxProfessional Services IndustryIndustrials SectorNYSE Exchange
Market Cap$22.63B$7.95B$10.63B$24.21B
Dividend Yield1.16%3.73%97.24%3.71%
P/E Ratio34.1937.5726.4730.22
Price / Sales3.7624.83425.0795.75
Price / Cash13.8223.2924.3119.80
Price / Book5.067.134.834.90
Net Income$660.30M$236.65M$612.94M$1.07B
7 Day Performance10.04%1.53%-1.76%-0.20%
1 Month Performance13.05%7.64%2.24%2.85%
1 Year Performance-23.69%-4.66%11.41%14.47%

Equifax Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EFX
Equifax
4.3002 of 5 stars
$194.54
+1.0%
$216.89
+11.5%
-24.3%$22.63B$6.07B34.1915,000
CRAI
Charles River Associates
4.4216 of 5 stars
$164.21
-2.4%
$245.00
+49.2%
-10.3%$1.03B$751.58M21.87940
APTV
Aptiv
4.8157 of 5 stars
$50.05
+1.0%
$76.50
+52.8%
-38.3%$10.39B$20.40B47.22140,000
G
Genpact
4.2102 of 5 stars
$33.77
-0.3%
$39.33
+16.5%
-18.0%$5.67B$5.25B10.02146,500
IQV
IQVIA
4.0719 of 5 stars
$241.09
+1.9%
$241.88
+0.3%
+36.2%$39.68B$16.31B29.9193,000

Related Companies and Tools


This page (NYSE:EFX) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners